MX2007001996A - Nanoparticulas y metodo para su produccion. - Google Patents
Nanoparticulas y metodo para su produccion.Info
- Publication number
- MX2007001996A MX2007001996A MX2007001996A MX2007001996A MX2007001996A MX 2007001996 A MX2007001996 A MX 2007001996A MX 2007001996 A MX2007001996 A MX 2007001996A MX 2007001996 A MX2007001996 A MX 2007001996A MX 2007001996 A MX2007001996 A MX 2007001996A
- Authority
- MX
- Mexico
- Prior art keywords
- nanoparticles
- gelatin
- less
- production
- definable
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 4
- 239000008273 gelatin Substances 0.000 abstract 4
- 229920000159 gelatin Polymers 0.000 abstract 4
- 235000019322 gelatine Nutrition 0.000 abstract 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
Con el fin de volver disponibles a nanoparticulas biodegradables lo que asegura un transporte uniforme y definible de sustancias activas y para proporcionar un procedimiento adecuado para la produccion de estas nanoparticulas al mismo tiempo, se sugiere que las nanoparticulas consistan esencialmente de un gel acuoso de gelatina, en donde el diametro promedio de las nanoparticulas sea como maximo de 350 nm, el indice de polidispersividad de las nanoparticulas es menor que o igual a 0.15 y en donde se utiliza una gelatina como material inicial para los procedimientos de produccion, su proporcion de gelatina con un peso molecular de menos de 65 kDa, en relacion a la gelatina total, es como maximo de 40% en peso.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004041340A DE102004041340A1 (de) | 2004-08-20 | 2004-08-20 | Nanopartikel und Verfahren zu deren Herstellung |
| PCT/EP2005/008954 WO2006021367A1 (de) | 2004-08-20 | 2005-08-18 | Nanopartikel und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007001996A true MX2007001996A (es) | 2007-05-10 |
Family
ID=35276582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007001996A MX2007001996A (es) | 2004-08-20 | 2005-08-18 | Nanoparticulas y metodo para su produccion. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080003292A1 (es) |
| EP (1) | EP1793810A1 (es) |
| JP (1) | JP2008510688A (es) |
| KR (1) | KR20070046850A (es) |
| CN (1) | CN1988892A (es) |
| AU (1) | AU2005276675A1 (es) |
| BR (1) | BRPI0514524A (es) |
| CA (1) | CA2575407A1 (es) |
| DE (1) | DE102004041340A1 (es) |
| IL (1) | IL180954A0 (es) |
| MX (1) | MX2007001996A (es) |
| NO (1) | NO20071458L (es) |
| NZ (1) | NZ551326A (es) |
| WO (1) | WO2006021367A1 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1973608A1 (en) | 2005-12-14 | 2008-10-01 | Cytos Biotechnology AG | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| WO2007072982A1 (en) * | 2005-12-20 | 2007-06-28 | Fujifilm Corporation | Protein nanoparticles and the use of the same |
| JP2007224012A (ja) * | 2006-01-30 | 2007-09-06 | Fujifilm Corp | 酵素架橋したタンパク質ナノ粒子 |
| NZ573622A (en) | 2006-06-12 | 2011-12-22 | Cytos Biotechnology Ag | Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
| JP2008001764A (ja) * | 2006-06-21 | 2008-01-10 | Gunma Univ | タンパク質からなる粒子状成形体の製造方法及び、該方法により得られたタンパク質からなる粒子状成形体 |
| JP5275561B2 (ja) * | 2006-10-30 | 2013-08-28 | 富士フイルム株式会社 | 水分散可能なナノ粒子 |
| DE602007002784D1 (de) * | 2007-03-16 | 2009-11-26 | Univ Nat Chi Nan | Bioabbaubares Material mit Nanoporen und elektrischer Leitfähigkeit sowie Herstellungsverfahren dafür |
| JP2008260705A (ja) * | 2007-04-11 | 2008-10-30 | Fujifilm Corp | 注射用組成物 |
| JP2008297241A (ja) * | 2007-05-31 | 2008-12-11 | Fujifilm Corp | ニキビ用皮膚外用剤 |
| DE102007041625A1 (de) * | 2007-09-03 | 2009-03-05 | Sinn, Hannsjörg, Dr. | Neue Gelatine-Wirkstoff-Konjugate |
| KR102302069B1 (ko) | 2010-11-10 | 2021-09-14 | 인리젠 | 장기 확대를 위한 주사가능 제제 |
| EP2540287A1 (en) | 2011-07-01 | 2013-01-02 | FutureChemistry | Continuous flow production of gelatin nanoparticles |
| DE102011052396A1 (de) * | 2011-08-04 | 2013-02-07 | Gelita Ag | Verfahren zur Herstellung einer stabilen Dispersion von Nanopartikeln, hergestellte Dispersion und deren Verwendung |
| US20190002530A1 (en) * | 2015-12-25 | 2019-01-03 | Konica Minolta, Inc. | Gelatin particles, method for producing gelatin particles, gelatin particle-containing cell, and method for producing gelatin particle-containing cell |
| US11207258B2 (en) | 2016-01-25 | 2021-12-28 | Suntory Holdings Limited | Capsule containing functional substance and method for manufacturing said capsule |
| CN107376008B (zh) | 2017-07-21 | 2019-10-22 | 深圳华诺生物科技有限公司 | 一种无机纳米颗粒-明胶核壳结构复合材料颗粒的制备方法 |
| WO2021132741A1 (ko) * | 2019-12-23 | 2021-07-01 | 주식회사 피엘마이크로메드 | 색전 시술 입자 및 이의 제조방법 |
| KR102386631B1 (ko) * | 2020-04-09 | 2022-04-15 | 주식회사 피엘마이크로메드 | 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물 |
| WO2021206440A1 (ko) * | 2020-04-09 | 2021-10-14 | 주식회사 피엘마이크로메드 | 색전 시술용 마이크로 비드 및 증식성 질환 치료용 조성물 |
| KR102645182B1 (ko) * | 2021-08-23 | 2024-03-07 | 전남대학교산학협력단 | 젤라틴 가교입자의 제조 방법 |
| US20240049705A1 (en) * | 2022-07-26 | 2024-02-15 | Industry Foundation Of Chonnam National University | Composition for enhancing growth of plants |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| EP0615445B1 (de) * | 1991-12-05 | 1996-05-15 | ALFATEC-PHARMA GmbH | Pharmazeutisch applizierbares nanosol und verfahren zu seiner herstellung |
| DE4140195C2 (de) * | 1991-12-05 | 1994-10-27 | Alfatec Pharma Gmbh | Pharmazeutisch applizierbares Nanosol und Verfahren zu seiner Herstellung |
| DE4140185C2 (de) * | 1991-12-05 | 1996-02-01 | Alfatec Pharma Gmbh | Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung |
| DE4140183C2 (de) * | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Retardform für ein Flurbiprofen enthaltendes Arzneimittel |
| DE19838189A1 (de) * | 1998-08-24 | 2000-03-02 | Basf Ag | Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung |
| WO2000059538A2 (en) * | 1999-04-08 | 2000-10-12 | The John Hopkins University | Antigen-specific induction of peripheral immune tolerance |
| CA2498207C (en) * | 2002-09-11 | 2012-03-13 | Elan Pharma International Ltd. | Gel-stabilized nanoparticulate active agent compositions |
| CA2435632A1 (en) * | 2003-07-21 | 2005-01-21 | Warren Hugh Finlay | Formulation of powder containing nanoparticles for aerosol delivery to the lung |
-
2004
- 2004-08-20 DE DE102004041340A patent/DE102004041340A1/de not_active Withdrawn
-
2005
- 2005-08-18 EP EP05783457A patent/EP1793810A1/de not_active Withdrawn
- 2005-08-18 CN CNA2005800213793A patent/CN1988892A/zh active Pending
- 2005-08-18 AU AU2005276675A patent/AU2005276675A1/en not_active Abandoned
- 2005-08-18 KR KR1020077003208A patent/KR20070046850A/ko not_active Withdrawn
- 2005-08-18 JP JP2007526390A patent/JP2008510688A/ja active Pending
- 2005-08-18 CA CA002575407A patent/CA2575407A1/en not_active Abandoned
- 2005-08-18 WO PCT/EP2005/008954 patent/WO2006021367A1/de not_active Ceased
- 2005-08-18 BR BRPI0514524-4A patent/BRPI0514524A/pt not_active IP Right Cessation
- 2005-08-18 NZ NZ551326A patent/NZ551326A/en unknown
- 2005-08-18 MX MX2007001996A patent/MX2007001996A/es unknown
-
2007
- 2007-01-25 IL IL180954A patent/IL180954A0/en unknown
- 2007-02-16 US US11/675,643 patent/US20080003292A1/en not_active Abandoned
- 2007-03-19 NO NO20071458A patent/NO20071458L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070046850A (ko) | 2007-05-03 |
| EP1793810A1 (de) | 2007-06-13 |
| CN1988892A (zh) | 2007-06-27 |
| NZ551326A (en) | 2010-04-30 |
| JP2008510688A (ja) | 2008-04-10 |
| AU2005276675A1 (en) | 2006-03-02 |
| US20080003292A1 (en) | 2008-01-03 |
| NO20071458L (no) | 2007-03-19 |
| DE102004041340A1 (de) | 2006-02-23 |
| WO2006021367A1 (de) | 2006-03-02 |
| BRPI0514524A (pt) | 2008-06-10 |
| CA2575407A1 (en) | 2006-03-02 |
| IL180954A0 (en) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007001996A (es) | Nanoparticulas y metodo para su produccion. | |
| EA201170039A1 (ru) | Полимерные частицы, нагруженные лекарственным средством, и способы их получения и применения | |
| WO2004087007A3 (en) | Hydrogel string medical device | |
| BR0215155A (pt) | Ëxido de zinco de superfìcie modificada para produção de dispersões de micropartìculas | |
| WO2002085952A3 (de) | Modifizierte polymere mit einem hohen anteil an cis-ständigen doppelbindungen, ein verfahren zu deren herstellung sowie deren verwendung | |
| ATE380250T1 (de) | Bacillus subtilis var. chungkookjang zur herstellung von poly-gamma-glutaminsäure mit hohem molekulargewicht | |
| MXPA05011098A (es) | Composicion de polisacaridos entrelazados. | |
| WO2007109069A3 (en) | Hydrophobic derivatives of natural biodegradable polysaccharides and uses thereof | |
| WO2005012364A3 (fr) | Matrice complexe a usage biomedical | |
| ATE508646T1 (de) | Proteinpulverzusammensetzung | |
| AU2010210593A8 (en) | Nanoscale platinum compounds and methods of use thereof | |
| CL2009000573A1 (es) | Composicion farmaceutica inyectable intraocular en forma de suspension acuosa que no contiene preservante, que consiste de acetonido de triamcinolona, carboximetilcelulosa de sodio, 0,002-0,02% de polisorbato 80, cloruros para ajustar la tonicidad, agente tamponante, agua y agente de ajuste de ph; uso para tratar el ojo. | |
| AR055946A1 (es) | Composiciones polimericas de hidrogeles | |
| WO2010136694A3 (fr) | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme | |
| TW200801113A (en) | The polylactic acid composition and the deep dyeing fiber manufactured from the same | |
| WO2020139619A3 (en) | Reduction of pathogenic bacteria using arginine | |
| DE502004001971D1 (de) | Wässrige zusammensetzung und deren verwendung zur papierherstellung | |
| EP4273239A3 (en) | Polymeric particles containing microorganisms | |
| CA2513502A1 (en) | Partially biodegradable temperature and ph sensitive hydrogel | |
| WO2010010399A3 (en) | Honey wound dressing | |
| TW200740856A (en) | Synthetic rubber with narrow molecular weight distribution, its use and a process for its preparation | |
| ATE547479T1 (de) | Polycarbonatzusammensetzungen, herstellungsverfahren dafür und artikel damit | |
| EP1760115A4 (en) | COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
| WO2021050779A3 (en) | Anti-nucleolin agent-peg-conjugated nanoparticles | |
| BRPI0417644A (pt) | método para preparar um produto alimentìcio que não seja de laticìnio, composição para texturização, produto alimentìcio que não seja de laticìnio, e, uso de ácido hialurÈnico e de um segundo agente texturizador |